Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease [Phase 4]
A Phase 4 trial comparing tofacitinib versus methotrexate in patients with rheumatoid arthritis and interstitial lung disease has been termi…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: ConsideRAte Study - Splenic Stimulation for RA [NA]
This update indicates the ConsideRAte study on splenic stimulation for rheumatoid arthritis is currently recruiting.
-
FDA approval · 2024-05-21FDA Approved: CYCLOSPORINE — Original Application (Devatis Inc.)
FDA approved Devatis Inc.'s cyclosporine as a generic drug under an original ANDA (ANDA209811).
-
FDA approval · 2024-05-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for hydroxychloroquine sulfate from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis [NA]
This update describes the completion of a study evaluating a new screening method for sarcopenia in people with rheumatoid arthritis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Clinical Evaluation of Vanguard DD RP [NA]
Status update on an ongoing clinical evaluation of Vanguard DD RP for knee osteoarthritis and post-traumatic osteoarthritis, with rheumatoid…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet s…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study
This clinical trial update describes a case-control study on how rheumatoid arthritis affects body composition, bone marrow adiposity, and b…
-
FDA approval · 2024-05-14FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) from Pfizer, granting an additional regulatory action under NDA 213082.
-
FDA approval · 2024-05-14FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for XELJANZ XR (tofacitinib) from Pfizer, introducing the extended-release formulation. Submission s…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Tapering of Biologics in Inflammatory Arthritis Patients in Remission [NA]
Clinical trial update from the University of Manchester on tapering biologic therapies in rheumatoid arthritis and psoriatic arthritis patie…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Acupressure in Rheumatoid Arthritis [NA]
Completed clinical trial evaluating acupressure for rheumatoid arthritis with results posted May 9, 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Rheumatoid Arthritis Adrenal Recovery Study
The University of Edinburgh-based trial on adrenal recovery in rheumatoid arthritis patients has completed. No specific results are provided…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Muscle Wasting and Rheumatoid Arthritis Flares [NA]
A clinical trial update describes a Leeds Beckett University study on muscle wasting and rheumatoid arthritis flares, currently not yet recr…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Adversity and Its Association With the Development and Expression of Rheumatic Diseases
Ongoing clinical trial exploring how adversity influences the development and expression of rheumatic diseases, including rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: ROSA Robot Used in Total Knee Replacement Post Market Study [NA]
Post-market clinical trial update evaluating the ROSA robotic system for total knee replacement; results have been posted.
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
A clinical trial is recruiting to define the molecular and radiologic phenotype of progressive rheumatoid arthritis-associated interstitial …
-
FDA approval · 2024-05-01FDA Approved: ETODOLAC — Original Application (Ipca Laboratories Limited)
FDA approved Etodolac from Ipca Laboratories Limited as a generic product (Original Application under ANDA 204729). It is indicated for reli…
-
FDA approval · 2024-04-30FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for ABRILADA (adalimumab-afzb) from Pfizer Laboratories Div Pfizer Inc, authorizing its use as a…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
A clinical trial is evaluating whether a molecular signature response classifier can guide the choice among JAK inhibitors, T-cell inhibitor…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis [NA]
Clinical trial update on SIMPLI.REHAB digital rehabilitation for hand arthritis, currently not yet recruiting.
-
FDA approval · 2024-04-26FDA Approved: RINVOQ — Original Application (AbbVie Inc.)
The FDA approved Rinvoq (upadacitinib) from AbbVie under an Original Application NDA, granting the drug its initial US marketing authorizati…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Korean College of Rheumatology Biologics and Targeted Therapy Registry
A registry study in Korea tracking biologics and targeted therapies for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthriti…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study on the Prevention and Treatment of GIOP With Eldecalcitol [Phase 4]
Phase 4 clinical trial update evaluating eldecalcitol for prevention and treatment of glucocorticoid-induced osteoporosis, with study popula…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Use of Tocilizumab Drug Levels to Optimize Treatment in RA [Phase 4]
A Phase 4 clinical trial exploring the use of tocilizumab drug levels to optimize treatment in rheumatoid arthritis.